Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 7,082 $ 8,137
Accounts receivable 12 269
Lease receivable, current portion 15,527 920
Inventory 278 123
Assets held for sale 47 2,633
Prepaid expenses and other current assets 263 356
Total current assets 23,209 12,438
Non-current assets    
Property and equipment, net 7,343 2,367
Intellectual property, net 461 640
Investment in LINICO 2,000 1,500
Lease receivable, non-current portion 0 15,528
Other assets 489 796
Total non-current assets 10,293 20,831
Total assets 33,502 33,269
Current liabilities    
Accounts payable 1,075 685
Accrued liabilities 1,780 3,005
Building purchase deposit, current portion 3,250 0
Lease liability, current portion 307 388
Note payable 5,899 0
Total current liabilities 12,311 4,078
Building purchase deposit, non-current portion 0 1,328
Lease liability, non-current portion 275 330
Total liabilities 12,586 5,736
Commitments and contingencies (see Note 15)
Stockholders’ equity    
Common stock; $0.001 par value; 200,000,000 shares authorized; 79,481,751 and 70,416,552 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively 79 70
Additional paid-in capital 220,114 211,309
Accumulated deficit (199,277) (183,846)
Total stockholders’ equity 20,916 27,533
Total liabilities and stockholders’ equity $ 33,502 $ 33,269